Order Article Reprints

Liao Y, Badmann S, Kaltofen T, Mayr D, Schmoeckel E, Deuster E, Mannewitz M, Landgrebe S, Kolben T, Hester A, et al. Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer as a Protective Factor and Potential Negative Regulator of the Wnt Signaling Pathway. Biomedicines. 2021; 9(7):706. https://doi.org/10.3390/biomedicines9070706

Liao, Yue, Susann Badmann, Till Kaltofen, Doris Mayr, Elisa Schmoeckel, Eileen Deuster, Mareike Mannewitz, Sarah Landgrebe, Thomas Kolben, Anna Hester, and et al. 2021. "Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer as a Protective Factor and Potential Negative Regulator of the Wnt Signaling Pathway" Biomedicines 9, no. 7: 706. https://doi.org/10.3390/biomedicines9070706

Liao, Y., Badmann, S., Kaltofen, T., Mayr, D., Schmoeckel, E., Deuster, E., Mannewitz, M., Landgrebe, S., Kolben, T., Hester, A., Beyer, S., Burges, A., Mahner, S., Jeschke, U., Trillsch, F., & Czogalla, B. (2021). Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer as a Protective Factor and Potential Negative Regulator of the Wnt Signaling Pathway. Biomedicines, 9(7), 706. https://doi.org/10.3390/biomedicines9070706